参仙胃康治疗慢性萎缩性胃炎66例临床探究.doc

参仙胃康治疗慢性萎缩性胃炎66例临床探究【中图分类号】R735.2 【文献标识码】A 【文章编号】1672－3783(2012)07－0369－01 【摘要】:目的 研究参仙胃康在治疗慢性萎缩性胃炎方面的疗效。方法 治疗组患者服用中药参仙胃康三个疗程，对照组患者服用维酶素胶囊和维生素E三个疗程。结果 治疗组临床疗效总有效率为90.9%，胃镜疗效总有效率为87.9%，病理疗效总有效率为75.7%，灭HP疗效总有效率60.64％，而对照组在上述各个方面的有效率分别为46.6％、46．6％、46．6％和26．6％，两组各项疗效进行比较，差异非常显著（P0.05），具有统计学意义。结论 在中西医理论双蘑指导下，组方用药采取中医宏观辨证与西医微观辨病相结合的方法，运用针对性强的中药治疗CAG，是提高中医治疗本病疗效的捷经。 【关键词】:参仙胃康;慢性萎缩性胃炎;胃癌 【Abstract】 Objective To study the Shenxian Weikang in treatment of chronic atrophic gastritis with respect to efficacy. Methods the treatment group patients take medicine Shen Xian gastric Kang San treatment, the control group patients taking Weimeisu capsule and vitamin E three treatment. Results the treatment group curative effect the total efficiency of 90.9%, gastroscopy effect the total efficiency of 87.9%, pathological effect the total efficiency of 75.7%, and HP effect the total efficiency of 60.64%, while the control group in the aspects of efficiency were 46.6%,46.6%,46.6% and26.6%, two groups of the therapeutic effects were compared, the difference is very remarkable ( P 0.05), with statistical significance. Conclusion in the theory of traditional Chinese and Western medicine under the guidance of double mushroom, prescription medication of traditional Chinese medicine and Western medicine to take macroscopic differentiation microscopic disease differentiation combined method, use of targeted therapy of traditional Chinese medicine TCM treatment of CAG, is to improve the therapeutic effect of this disease by the Czech republic. 【Key words】: Shen Xian Weikang; chronic atrophic gastritis; gastric cancer 慢性萎缩性胃炎(CAG)伴肠上皮化生(IM)和胃粘膜不典型增生(ATP)是临床上常见的消化系统疾病之一［1］。早在1972年WHO就将其列为胃癌前期状态之一。近年来，笔者根据痰瘀相结，久病人络的病理特点．采用健脾益气，祛痰散瘀，消痞生新之法，治疗CAG患者66例，疗效满意，并设维酶素作对照。报告如下： 1 临床资料 1.1 一般资料：采用随机法分组，其中治疗组66例，对照组30例；男56例，女40例；年龄20-30岁，9例，30-40岁，57例，40-60岁，30例；病程：1-5年，26例，5-10年，43例，10年及以上，27例；职业：工人40例，农民50例，干部6例。 1.2 主要临床症状及合并症： 两组临床症状主要见脘腹痞满，嘈杂隐痛，时或刺痛隐隐，夜甚于昼，不思饮食，食后诸症加剧，咽干口粘不欲饮，便溏或不爽；精神疲倦，